Skip to content
Open access · CC-BY via OpenAlex

Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma

Ajay Kumar, Pritish Nilednu, Azad Kumar, Nilesh Kumar Sharma

Tumor Biology · 2017 · ▲ 4 citations

Abstract

In the last decade, implications of human telomerase reverse transcriptase (hTERT), a component of ribonucleoprotein telomerase in aging, senescence(definition), and stem cell are highly evident. Besides, the activation of hTERT is also being documented several cancer types including carcinoma. The awakening of telomerase during carcinoma initiation and development is being seen with different perspectives including genetic and epigenetic tools and events. In view of several tumor progenitors genes (also referred as epigenetic mediators), telomerase is placed as key enzyme to achieve the carcinoma phenotype and sustain during the progression. It is true that swaying of telomerase in carcinoma could be facilitated with dedicated set of epigenetic modulators and modifiers players. These epigenetic alterations are heritable, potentially reversible, and seen as the epigenetic signature of carcinoma. Several papers converge to suggest that DNA methylation, histone modification, and small non-coding RNAs are the widely appreciated epigenetic changes towards hTERT modulation. In this review, we summarize the contribution of epigenetic factors in the telomerase activation and discuss potential avenues to achieve therapeutic intervention in carcinoma.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1177/1010428317695951
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Kumar, A., Nilednu, P., Kumar, A., &amp; Sharma, N.K. (2017). Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma. <em>Tumor Biology</em>. https://doi.org/10.1177/1010428317695951
Vancouver
Kumar A, Nilednu P, Kumar A, Sharma NK. Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma. Tumor Biology. 2017. doi:10.1177/1010428317695951.
BibTeX
@article{ajay2017Epigen, title = {Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma}, author = {Ajay Kumar and Pritish Nilednu and Azad Kumar and Nilesh Kumar Sharma}, journal = {Tumor Biology}, year = {2017}, doi = {10.1177/1010428317695951}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings